CAS-59-92-7 | API EU Written Confirmation | WC | Pharmacompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

CAS-59-92-7
EU WC

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

CAS-59-92-7

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

33 API Suppliers, 20 USDMF, 13 CEP/COS, 4 JDMF, 2 EU WC, 9 KDMF, 12 NDC API, 14 Listed Suppliers, $ API Reference Price

33 API Suppliers
20 USDMF
13 CEP/COS
4 JDMF
2 EU WC
9 KDMF
12 NDC API
14 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

38 Drugs in Development

38 Drugs in Development

INTERMEDIATES

5 Intermediates Suppliers

5 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

396 FDF Dossiers, 125 FDA Orange Book, 189 Europe, 25 Canada, 14 South Africa, 43 Listed Dossiers

396 FDF Dossiers
125 FDA Orange Book
189 Europe
25 Canada
14 South Africa
43 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG;100MG, TABLET;ORAL - 25MG;100MG, TABLET;ORAL - 25MG;250MG, TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 23.75MG;95MG, CAPSULE, EXTENDED RELEASE;ORAL - 36.25MG;145MG, CAPSULE, EXTENDED RELEASE;ORAL - 48.75MG;195MG, CAPSULE, EXTENDED RELEASE;ORAL - 61.25MG;245MG, TABLET;ORAL - 12.5MG;200MG;50MG, TABLET;ORAL - 18.75MG;200MG;75MG, TABLET;ORAL - 25MG;200MG;100MG, TABLET;ORAL - 31.25MG;200MG;125MG, TABLET;ORAL - 37.5MG;200MG;150MG, TABLET;ORAL - 50MG;200MG;200MG

TABLET;ORAL - 10MG;100MG
TABLET;ORAL - 25MG;100MG
TABLET;ORAL - 25MG;250MG
TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 23.75MG;95MG
CAPSULE, EXTENDED RELEASE;ORAL - 36.25MG;145MG
CAPSULE, EXTENDED RELEASE;ORAL - 48.75MG;195MG
CAPSULE, EXTENDED RELEASE;ORAL - 61.25MG;245MG
TABLET;ORAL - 12.5MG;200MG;50MG
TABLET;ORAL - 18.75MG;200MG;75MG
TABLET;ORAL - 25MG;200MG;100MG
TABLET;ORAL - 31.25MG;200MG;125MG
TABLET;ORAL - 37.5MG;200MG;150MG
TABLET;ORAL - 50MG;200MG;200MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Evonik, 4 Rochem International Inc, 20 SPI Pharma, 2 Seqens, 5 DKSH, 3 Jai Radhe Sales, 7 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 15 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 29 BASF, 12 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 12 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 The Dow Chemical Company, 3 Ulanqab Kema New Material, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

93 Fillers, Diluents & Binders, 65 Coating Systems & Additives, 47 Direct Compression, 46 Disintegrants & Superdisintegrants, 39 Controlled & Modified Release, 32 Thickeners and Stabilizers, 31 Solubilizers, 31 Granulation, 25 Taste Masking, 23 Lubricants & Glidants, 23 Film Formers & Plasticizers, 22 Parenteral, 21 Chewable & Orodispersible Aids, 21 Co-Processed Excipients, 13 Topical, 9 API Stability Enhancers, 8 Emulsifying Agents, 7 Rheology Modifiers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 1 Soft Gelatin

93 Fillers, Diluents & Binders
65 Coating Systems & Additives
47 Direct Compression
46 Disintegrants & Superdisintegrants
39 Controlled & Modified Release
32 Thickeners and Stabilizers
31 Solubilizers
31 Granulation
25 Taste Masking
23 Lubricants & Glidants
23 Film Formers & Plasticizers
22 Parenteral
21 Chewable & Orodispersible Aids
21 Co-Processed Excipients
13 Topical
9 API Stability Enhancers
8 Emulsifying Agents
7 Rheology Modifiers
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

7 DATA COMPILATION #PharmaFlow, 94 NEWS #PharmaBuzz

7 DATA COMPILATION #PharmaFlow
94 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

176 Finished Drug Prices, 16 Annual Reports

176 Finished Drug Prices
16 Annual Reports

MARKET PLACE

23 APIs, 5 FDF Dossiers

23 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

111 US Patents, 4 US Exclusivities

111 US Patents
4 US Exclusivities

REF. STANDARDS & IMPURITIES

1 EDQM, 3 USP, 5 Others

1 EDQM
3 USP
5 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 86 Xls

Filters

Reset all filters

Filters

FILTER :

filter Name of the Firm Reset all filters

2 All

01 1Divi’s Laboratories

02 1M/s. Glochem Industries Ltd

filter Product Name Reset all filters

2 All

01 1Levodopa (IP/BP/USP/Ph. Eur)

02 1Levodopa (IP/USP/BP/Ph. Eur.)

filter WC Number Reset all filters

2 All

01 1WC-0029

02 1WC-0030

filter Country Reset all filters

2 All

01 2India

List of Suppliers

Product Main Page

01

Divis Laboratories

Pharmtech & Ingredients

Not Confirmed

Divis Laboratories

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Levodopa (IP/BP/USP/Ph. Eur)

Date of Issue : 2019-06-17

Valid Till : 2022-06-16

Written Confirmation Number : WC-0030

Address of the Firm : Unit-II, Annavaram(Post), Chippada Village, Beemunipatnam Mandal, Visakhapatan...

Product Web Link

Digital Content

Corporate PDF

02

Glochem Industries

Pharmtech & Ingredients

Not Confirmed

Glochem Industries

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Levodopa (IP/USP/BP/Ph. Eur.)

Date of Issue : 2013-06-11

Valid Till : 2016-06-05

Written Confirmation Number : WC-0029

Address of the Firm : Unit-II, Sy. No. 36, 37 and 46, Plot No. 77, J. N. Pharmacity, Thanam (V), Paraw...

Portfolio PDF

Product Web Link

Digital Content

CAS-59-92-7 Manufacturers | Traders | Suppliers

CAS-59-92-7 Manufacturers, Traders, Suppliers 1

52

We have 2 companies offering CAS-59-92-7

Get in contact with the supplier of your choice:

Divis Laboratories
Glochem Industries

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?